Features of H5N1 Influenza Viruses in Dairy Cows May Facilitate Infection, Transmission in Mammals

A series of experiments with highly pathogenic H5N1 avian influenza (HPAI H5N1) viruses circulating in infected U.S. dairy cattle found that viruses derived from lactating dairy cattle induced severe disease in mice and ferrets when administered via intranasal inoculation.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

How COVID-19 “Breakthrough” Infections Alter Your Immune Cells

Antibodies May Aid Effort to Fight Influenza B: Study

N95 Masks Nearly Perfect at Blocking COVID, UMD Study Shows

USF Using AI to Help Combat Malaria in Africa

UF Awarded NIH Funding for New Malaria Research Center

Creating a Vaccine for an Ancient, All-Too-Current Disease

Rocketvax Announces Collaboration with the US National Institutes of Health (NIH) for Clinical Trial of Nasal, Live-Attenuated NextGen SARS-CoV-2 Vaccine

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://rocketvax.com/news/rocketvax-announces-collaboration-with-the-us-national-institutes-of-health
Research Institution
Rocketvax
Short Title
Rocketvax Announces Collaboration with the US National Institutes of Health (NIH) for Clinical Trial of Nasal, Live-Attenuated NextGen SARS-CoV-2 Vaccine
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh

Nearly All Syphilis Strains in U.S. Resistant to Azithromycin

NIH-Sponsored Trial of Nasal COVID-19 Vaccine Opens

A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COVID-19, is now enrolling healthy adults at three sites in the United States.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Subscribe to Emerging Infectious Diseases/Pathogens